Bioethics (BOTH) 10-Q 15 Aug 22 2022 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2022	Aug. 12, 2022
Details
Registrant CIK	0000894560
Fiscal Year End	--12-31
Registrant Name	BIOETHICS, LTD.
SEC Form	10-Q
Period End date	Jun. 30, 2022
Tax Identification Number (TIN)	87-0485312
Number of common stock shares outstanding		1,135,194
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Shell Company	true
Small Business	true
Emerging Growth Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	33-55254-41
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	1661 Lakeview Circle
Entity Address, City or Town	Ogden
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84403
Country Region	801
City Area Code	399
Local Phone Number	3632
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash and cash equivalents	$ 294	$ 734
Total Current Assets	294	734
TOTAL ASSETS	294	734
CURRENT LIABILITIES
Accounts payable	90,870	79,601
Accounts payable - related party	5,500	7,500
Accrued interest - related parties	57,859	45,547
Accrued interest	68,693	58,615
Convertible notes payable	35,000	35,000
Notes payable	160,000	150,000
Notes payable - related parties	218,584	210,384
Total Current Liabilities	636,506	586,647
TOTAL LIABILITIES	636,506	586,647
STOCKHOLDERS' DEFICIT
Preferred stock, $0.01 par value; 25,000,000 shares authorized, -0- shares issued and outstanding	0	0
Common stock, $0.001 par value; 250,000,000 shares authorized, 1,135,194 shares issued and outstanding	1,135	1,135
Additional paid-in capital	500,479	500,479
Accumulated deficit	(1,137,826)	(1,087,527)
Total Stockholders' Deficit	(636,212)	(585,913)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 294	$ 734

Condensed Balance Sheets - Pare

Condensed Balance Sheets - Parenthetical - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Details
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	25,000,000	25,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	250,000,000	250,000,000
Common Stock, Shares, Issued	1,135,194	1,135,194
Common Stock, Shares, Outstanding	1,135,194	1,135,194

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Details
NET REVENUES	$ 0	$ 0	$ 0	$ 0
OPERATING EXPENSES
General and administrative	17,195	18,250	27,909	32,190
Total Operating Expenses	17,195	18,250	27,909	32,190
LOSS FROM OPERATIONS	(17,195)	(18,250)	(27,909)	(32,190)
OTHER INCOME (EXPENSES)
Interest expense	(11,425)	(11,633)	(22,390)	(25,868)
Total Other Income (Expenses)	(11,425)	(11,633)	(22,390)	(25,868)
NET LOSS BEFORE INCOME TAXES	(28,620)	(29,883)	(50,299)	(58,058)
PROVISION FOR INCOME TAXES	0	0	0	0
NET LOSS	$ (28,620)	$ (29,883)	$ (50,299)	$ (58,058)
BASIC AND DILUTED LOSS PER SHARE	$ (0.03)	$ (0.03)	$ (0.04)	$ (0.05)
SHARES OUTSTANDING	1,135,194	1,135,194	1,135,194	1,135,194

Condensed Statements of Stockho

Condensed Statements of Stockholders' Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	$ 1,135	$ 500,479	$ (980,344)	$ (478,730)
NET LOSS	0	0	(28,175)	(28,175)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2021	$ 1,135	500,479	(1,008,519)	(506,905)
Shares, Outstanding, Ending Balance at Mar. 31, 2021	1,135,914
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	$ 1,135	500,479	(980,344)	(478,730)
NET LOSS				(58,058)
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2021	$ 1,135	500,479	(1,038,402)	(536,788)
Shares, Outstanding, Ending Balance at Jun. 30, 2021	1,135,914
Stockholders' Equity Attributable to Parent, Beginning Balance at Mar. 31, 2021	$ 1,135	500,479	(1,008,519)	(506,905)
Shares, Outstanding, Beginning Balance at Mar. 31, 2021	1,135,914
NET LOSS	$ 0	0	(29,883)	(29,883)
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2021	$ 1,135	500,479	(1,038,402)	(536,788)
Shares, Outstanding, Ending Balance at Jun. 30, 2021	1,135,914
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2021	$ 1,135	500,479	(1,087,527)	(585,913)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	1,135,914
NET LOSS	$ 0	0	(21,679)	(21,679)
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2022	$ 1,135	500,479	(1,109,206)	(607,592)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	1,135,914
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2021	$ 1,135	500,479	(1,087,527)	(585,913)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	1,135,914
NET LOSS				(50,299)
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2022	$ 1,135	500,479	(1,137,826)	(636,212)
Shares, Outstanding, Ending Balance at Jun. 30, 2022	1,135,914
Stockholders' Equity Attributable to Parent, Beginning Balance at Mar. 31, 2022	$ 1,135	500,479	(1,109,206)	(607,592)
Shares, Outstanding, Beginning Balance at Mar. 31, 2022	1,135,914
NET LOSS	$ 0	0	(28,620)	(28,620)
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2022	$ 1,135	$ 500,479	$ (1,137,826)	$ (636,212)
Shares, Outstanding, Ending Balance at Jun. 30, 2022	1,135,914

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
NET LOSS	$ (50,299)	$ (58,058)
Adjustments to reconcile net loss to net cash
Amortization of debt discount	0	2,718
Depreciation	0	143
Changes in operating assets and liabilities
Accounts payable	11,269	20,698
Accounts payable - related party	(2,000)	3,000
Accrued interest - related parties	12,312	13,119
Accrued interest	10,078	10,030
Net Cash Used by Operating Activities	(18,640)	(8,350)
CASH FLOWS FROM INVESTING ACTIVITIES	0	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable	10,000	0
Proceeds from notes payable - related parties	8,200	8,150
Net Cash Provided by Financing Activities	18,200	8,150
DECREASE IN CASH AND CASH EQUIVALENTS	(440)	(200)
BEGINNING OF PERIOD	734	667
END OF PERIOD	294	467
SUPPLEMENTAL DISCLOSURES
Cash paid for interest	0	0
Cash paid for income taxes	$ 0	$ 0

NOTE 1 SUMMARY OF SIGNIFICANT A

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2022
Notes
NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization - Bioethics, Ltd. (“the Company”) was organized under the laws of the State of Nevada on July 26, 1990. The Company was organized to provide a vehicle for participating in potentially profitable business ventures which may become available through the personal contacts of and at the complete discretion of the Company’s officers and directors. The Company has not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors. The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows for the six months ended June 30, 2022 and 2021 have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2021 audited financial statements. The results of operations for the six months ended June 30, 2022 are not necessarily indicative of the operating results for the full year.

NOTE 2 RELATED PARTY TRANSACTIO

NOTE 2 RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2022
Notes
NOTE 2 RELATED PARTY TRANSACTIONS	NOTE 2 - RELATED PARTY TRANSACTIONS Management Compensation - During the six months ended June 30, 2022 and 2021, the Company did not pay any compensation to its officers and directors. Beginning August 2017, the Company entered into an oral agreement to pay the Company’s President $500 per month as payment for use of his personal residence as the Company’s office and mailing address. The Company has recorded rent expense of $3,000 during each of the six months ended June 30, 2022 and 2021, which is included in the general and administrative expenses on the statements of operations, of which $5,500 and $7,500 remains payable at June 30, 2022 and December 31, 2021, respectively. On March 8, 2018, the Company entered into a promissory note with a newly-affiliated party in the amount of $43,250. The note is payable on demand and carries interest at 10% per annum. Interest expense for the six months ended June 30, 2022 and 2021 was $2,145 and $4,571, respectively, resulting in accrued interest of $18,651 and $16,506 at June 30, 2022 and December 31, 2021, respectively. Principal balance on the note at June 30, 2022 and December 31, 2021 was $43,250. On December 12, 2017, the Company entered into a promissory note with its President in the amount of $107,000. On various dates from the origin of the note through December 31, 2021, the officer advanced the Company an additional $80,820, and the Company made payments of $20,686, resulting in the total note principal balance of $167,134 at December 31, 2021. During the six months ended June 30, 2022 and 2021, the Company received an additional $8,200 and $8,150, respectively, and did not make any repayments of the principal balance resulting in the total note principal balance of $175,334 at June 30, 2022. The cumulative note balance is uncollateralized, due on demand, and carries interest at 12% per annum. Interest expense on the note for the six months ended June 30, 2022 and 2021 was $10,167 and $8,548, respectively, of which the Company repaid $—0- during the six months ended June 30, 2022, resulting in accrued interest totaling $39,208 and $29,041 at June 30, 2022 and December 31, 2021, respectively.

NOTE 3 - NOTES PAYABLE

NOTE 3 - NOTES PAYABLE	6 Months Ended
	Jun. 30, 2022
Notes
NOTE 3 - NOTES PAYABLE	NOTE 3 - NOTES PAYABLE On June 14, 2016, the Company issued a promissory note in the principal amount of $35,000 to an unaffiliated lender. The Note is due on demand at any time after its original maturity date of June 14, 2017, and carries an interest rate of 8% per annum. Interest expense for the six months ended June 30, 2022 and 2021 totaled $1,388 and $1,388, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $16,930 and $15,542, respectively. Principal balance due on the note at June 30, 2022 and December 31, 2021 was $35,000. On August 15, 2018, the Company issued a promissory note in the principal amount of $10,000 to an unaffiliated lender. The Note was due on November 15, 2018, is currently in default, and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2022 and 2021 totaled $595 and $595, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $3,902 and $3,307, respectively. Principal balance on the note at June 30, 2022 and December 31, 2021 was $10,000. On November 15, 2018, the Company issued a promissory note in the principal amount of $20,000 to an unaffiliated lender. The Note was due on February 15, 2019, is currently in default, and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2022 and 2021 totaled $1,190 and $1,190, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $7,805 and $6,615, respectively. Principal balance on the note at June 30, 2022 and December 31, 2021 was $20,000. On December 31, 2018, the Company issued a promissory note in the principal amount of $30,000 to an unaffiliated lender. The Note was due on December 31, 2019, is currently in default, and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2022 and 2021 totaled $1,785 and $1,785, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $11,707 and $9,922, respectively. Principal balance on the note at June 30, 2022 and December 31, 2021 was $30,000. On January 23, 2019, the Company issued a promissory note in the principal amount of $50,000 to an unaffiliated lender. The Note was due on January 23, 2021, is currently in default, and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2022 and 2021 totaled $2,975 and $2,975, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $19,512 and $16,537, respectively. Principal balance on the note at June 30, 2022 and December 31, 2021 was $50,000. On May 1, 2020, the Company issued a promissory note in the principal amount of $5,000 to an unaffiliated lender. The Note was due on May 1, 2021 and is now due on demand and carries an interest rate of 12% per annum. Interest expense for the six months ended June 30, 2022 and 2021 totaled $298 and $298, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $1,289 and $991, respectively. Principal balance on the note at June 30, 2022 and December 31, 2021 was $5,000. On April 18, 2022, the Company issued a promissory note in the principal amount of $10,000 to an unaffiliated lender. The Note is due on April 18, 2023 and carries an interest rate of 8% per annum. Interest expense for the six months ended June 30, 2022 and 2021 totaled $160 and $-0-, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $160 and $-0-, respectively. Principal balance on the note at June 30, 2022 and December 31, 2021 was $10,000 and $-0-, respectively.

NOTE 4 - CONVERTIBLE NOTE PAYAB

NOTE 4 - CONVERTIBLE NOTE PAYABLE	6 Months Ended
	Jun. 30, 2022
Notes
NOTE 4 - CONVERTIBLE NOTE PAYABLE	NOTE 4 – CONVERTIBLE NOTES PAYABLE On December 18, 2019, the Company issued a convertible promissory note in the original principal amount of $10,000 to a lender. The Note was due on June 18, 2020, is currently in default, and carries an interest rate of 8% per annum. The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $2.00 per share. The Company recognized a beneficial conversion feature and recorded a debt discount in the amount of $4,000, which was amortized over the life of the promissory note. At June 30, 2022 and December 31, 2021, the unamortized debt discount was $-0-, and the net convertible note balance was $10,000. The amortization of debt discount was $-0- during the six months ended June 30, 2022 and June 30, 2021. Interest expense for the six months ended June 30, 2022 and 2021 totaled $595 and $595, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $3,041 and $2,446, respectively. Principal balance on the note at June 30, 2022 and December 31, 2021 was $10,000. On June 9, 2020, the Company issued a convertible promissory note in the original principal amount of $10,000 to a lender. The Note was due on June 9, 2021, is currently in default, and carries an interest rate of 10% per annum. The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $2.50 per share. The Company recognized a beneficial conversion feature and recorded a debt discount in the amount of $6,200, which was amortized over the life of the promissory note. At June 30, 2022 and December 31, 2021, the unamortized debt discount was $-0, and the net convertible note balance was $10,000. The amortization of debt discount was $-0- and $2,718 during the six months ended June 30, 2022 and 2021, respectively. Interest expense for the six months ended June 30, 2022 and 2021 totaled $496 and $608, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $2,058 and $1,562. Principal balance on the note at June 30, 2022 and December 31, 2021 was $10,000. On August 3, 2020, the Company issued a convertible promissory note in the original principal amount of $15,000 to a lender. The Note was due on August 3, 2021, is currently in default, and carries an interest rate of 8% per annum. The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $7.00 per share. The Company did not recognize a beneficial conversion feature or debt discount as the conversion price was higher than the market price at the time of issuance of the note. Interest expense for the six months ended June 30, 2022 and 2021 totaled $595 and $595, respectively, resulting in accrued interest at June 30, 2022 and December 31, 2021 of $2,288 and $1,693. Principal balance on the note at June 30, 2022 and December 31, 2021 was $15,000.

NOTE 5 - EQUITY TRANSACTIONS

NOTE 5 - EQUITY TRANSACTIONS	6 Months Ended
	Jun. 30, 2022
Notes
NOTE 5 - EQUITY TRANSACTIONS	NOTE 5 – EQUITY TRANSACTIONS The Company is authorized to issue 250,000,000 shares of common stock. There were no equity transactions during the six months ended June 30, 2022 or 2021, resulting in 1,135,194 shares of common stock issued and outstanding at June 30, 2022 and December 31, 2021.

NOTE 6 - GOING CONCERN

NOTE 6 - GOING CONCERN	6 Months Ended
	Jun. 30, 2022
Notes
NOTE 6 - GOING CONCERN	NOTE 6 - GOING CONCERN The accompanying unaudited condensed financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has incurred losses since its inception totaling $1,137,826 and has no on-going operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans, additional sales of its common stock, or through a possible business combination. There is no assurance that the Company will be successful in raising this additional capital or in achieving profitable operations. In addition, the COVID-19 pandemic could have an impact on our ability to obtain financing to fund the operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

NOTE 7 - LOSS PER SHARE

NOTE 7 - LOSS PER SHARE	6 Months Ended
	Jun. 30, 2022
Notes
NOTE 7 - LOSS PER SHARE	NOTE 7 - LOSS PER SHARE The computation of basic loss per share is based on the weighted average number of shares outstanding during each period. The following data show the amounts used in computing loss per share for the six months ended: June 30, 2022 June 30, 2021 Net loss (numerator) $ (50,299) $ (58,058) Weighted average shares outstanding (denominator) 1,135,194 1,135,194 Basic and fully diluted net loss per share amount $ (0.04) $ (0.05) The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus the common stock equivalents as detailed in the following chart. For the six months ended June 30, 2022 and 2021, the inclusion of these shares on the statements of operations would have resulted in a weighted average shares fully diluted number that was anti-dilutive, and as such they are excluded. The following data show the fully diluted shares for the six months ended June 30, 2022 and 2021: June 30, 2022 2021 Basic weighted average shares outstanding 1,135,194 1,135,194 Convertible debt 13,750 11,143 Total 1,148,944 1,146,337

NOTE 8 - SUBSEQUENT EVENTS

NOTE 8 - SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2022
Notes
NOTE 8 - SUBSEQUENT EVENTS	NOTE 8 – SUBSEQUENT EVENTS The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and determined there are no events requiring disclosure.

NOTE 7 - LOSS PER SHARE_ Schedu

NOTE 7 - LOSS PER SHARE: Schedule of earnings per share (Tables)	6 Months Ended
	Jun. 30, 2022
Tables/Schedules
Schedule of earnings per share	June 30, 2022 June 30, 2021 Net loss (numerator) $ (50,299) $ (58,058) Weighted average shares outstanding (denominator) 1,135,194 1,135,194 Basic and fully diluted net loss per share amount $ (0.04) $ (0.05)

NOTE 7 - LOSS PER SHARE_ Sche_2

NOTE 7 - LOSS PER SHARE: Schedule of fully diluted shares (Tables)	6 Months Ended
	Jun. 30, 2022
Tables/Schedules
Schedule of fully diluted shares	June 30, 2022 2021 Basic weighted average shares outstanding 1,135,194 1,135,194 Convertible debt 13,750 11,143 Total 1,148,944 1,146,337

NOTE 2 RELATED PARTY TRANSACT_2

NOTE 2 RELATED PARTY TRANSACTIONS (Details) - USD ($)		3 Months Ended		6 Months Ended
	Dec. 31, 2020	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Mar. 08, 2018	Dec. 12, 2017
Notes payable - related parties		$ 218,584		$ 218,584		$ 210,384
Proceeds from notes payable - related parties				8,200	$ 8,150
Interest Expense		11,425	$ 11,633	22,390	25,868
Director 1
Operating Leases, Rent Expense				3,000	3,000
Notes payable - related parties		5,500		5,500		7,500
Newly Affiliated Party
Notes payable - related parties		18,651		18,651		16,506
Debt Instrument, Face Amount							$ 43,250
Debt Instrument, Interest Rate, Stated Percentage							10%
Interest Payable, Current		2,145		2,145		4,571
Long-term Debt, Gross		43,250		43,250		43,250
Sole Officer And Director
Notes payable - related parties		$ 175,334		$ 175,334		167,134
Debt Instrument, Face Amount								$ 107,000
Debt Instrument, Interest Rate, Stated Percentage		12%		12%
Interest Payable, Current		$ 39,208		$ 39,208		$ 29,041
Proceeds from notes payable - related parties	$ 80,820			8,200	8,150
Repayments of Related Party Debt	$ 20,686
Interest Expense				10,167	$ 8,548
Repayment of Notes Receivable from Related Parties				$ 0

NOTE 3 - NOTES PAYABLE (Details

NOTE 3 - NOTES PAYABLE (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Apr. 18, 2024	Apr. 18, 2022	Dec. 31, 2021	May 01, 2020	Jan. 23, 2019	Dec. 31, 2018	Nov. 15, 2018	Aug. 15, 2018	Jun. 14, 2016
Interest Expense	$ 11,425	$ 11,633	$ 22,390	$ 25,868
Promissory Note 1
Debt Instrument, Face Amount													$ 35,000
Debt Instrument, Interest Rate, Stated Percentage													8%
Interest Expense			1,388	1,388
Interest Payable, Current	16,930		16,930				$ 15,542
Long-term Debt, Gross							35,000
Promissory Note 2
Debt Instrument, Face Amount												$ 10,000
Debt Instrument, Interest Rate, Stated Percentage												12%
Interest Expense			595	595
Interest Payable, Current	3,902		3,902				3,307
Long-term Debt, Gross	10,000		10,000				10,000
Promissory Note 3
Debt Instrument, Face Amount											$ 20,000
Debt Instrument, Interest Rate, Stated Percentage											12%
Interest Expense			1,190	1,190
Interest Payable, Current	7,805		7,805				6,615
Long-term Debt, Gross	20,000		20,000				20,000
Promissory Note 4
Debt Instrument, Face Amount										$ 30,000
Debt Instrument, Interest Rate, Stated Percentage										12%
Interest Expense			1,785	1,785
Interest Payable, Current	11,707		11,707				9,922
Long-term Debt, Gross	30,000		30,000				30,000
Promissory Note 5
Debt Instrument, Face Amount									$ 50,000
Debt Instrument, Interest Rate, Stated Percentage									12%
Interest Expense			2,975	2,975
Interest Payable, Current	19,512		19,512				16,537
Long-term Debt, Gross	50,000		50,000				50,000
Promissory Note 6
Debt Instrument, Face Amount								$ 5,000
Debt Instrument, Interest Rate, Stated Percentage								12%
Interest Expense			298	298
Interest Payable, Current	1,289		1,289				991
Long-term Debt, Gross	5,000		5,000				5,000
Promissory Note 7
Debt Instrument, Face Amount						$ 10,000
Debt Instrument, Interest Rate, Stated Percentage					8%
Interest Expense			160	$ 0
Interest Payable, Current	160		160				0
Long-term Debt, Gross	$ 10,000		$ 10,000				$ 0

NOTE 4 - CONVERTIBLE NOTE PAY_2

NOTE 4 - CONVERTIBLE NOTE PAYABLE (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Amortization of debt discount			$ 0	$ 2,718
Interest Expense	$ 11,425	$ 11,633	22,390	25,868
A Lender
Debt Instrument, Face Amount	10,000		$ 10,000
Debt Instrument, Payment Terms			The Note was due on June 18, 2020, is currently in default, and carries an interest rate of 8% per annum
Debt Instrument, Convertible, Terms of Conversion Feature			The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $2.00 per share
Debt Instrument, Unamortized Discount	4,000		$ 4,000
Debt Instrument, Unamortized Discount, Current	0		0
Amortization of debt discount			0	0
Interest Expense			595	595
Interest Payable, Current	3,041		3,041		$ 2,446
Long-term Debt, Gross	10,000		10,000		10,000
A Lender (2)
Debt Instrument, Face Amount	10,000		$ 10,000
Debt Instrument, Payment Terms			The Note was due on June 9, 2021, is currently in default, and carries an interest rate of 10% per annum
Debt Instrument, Convertible, Terms of Conversion Feature			The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $2.50 per share
Debt Instrument, Unamortized Discount	6,200		$ 6,200
Debt Instrument, Unamortized Discount, Current	0		0		0
Amortization of debt discount			0	2,718
Interest Expense			496	608
Interest Payable, Current	2,058		2,058		1,562
Long-term Debt, Gross	10,000		10,000		10,000
A Lender (3)
Debt Instrument, Face Amount	15,000		$ 15,000
Debt Instrument, Payment Terms			The Note was due on August 3, 2021, is currently in default, and carries an interest rate of 8% per annum
Debt Instrument, Convertible, Terms of Conversion Feature			The Note is due and payable in full unless converted partially or in its entirety upon the election of the lender into fully paid and non-assessable shares of common stock of the Company at a conversion rate of $7.00 per share
Interest Expense			$ 595	$ 595
Interest Payable, Current	2,288		2,288		1,693
Long-term Debt, Gross	$ 15,000		$ 15,000		$ 15,000

NOTE 5 - EQUITY TRANSACTIONS (D

NOTE 5 - EQUITY TRANSACTIONS (Details) - shares	Jun. 30, 2022	Dec. 31, 2021
Details
Common Stock, Shares Authorized	250,000,000	250,000,000
Common Stock, Shares, Issued	1,135,194	1,135,194
Common Stock, Shares, Outstanding	1,135,194	1,135,194

NOTE 6 - GOING CONCERN (Details

NOTE 6 - GOING CONCERN (Details) - USD ($)	3 Months Ended				6 Months Ended		383 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022
Details
NET LOSS	$ (28,620)	$ (21,679)	$ (29,883)	$ (28,175)	$ (50,299)	$ (58,058)	$ 1,137,826

NOTE 7 - LOSS PER SHARE_ Sche_3

NOTE 7 - LOSS PER SHARE: Schedule of earnings per share (Details) - USD ($)	3 Months Ended				6 Months Ended		383 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022
Details
NET LOSS	$ (28,620)	$ (21,679)	$ (29,883)	$ (28,175)	$ (50,299)	$ (58,058)	$ 1,137,826
Weighted average shares outstanding (denominator)					1,135,194	1,135,194
Basic and fully diluted net loss per share amount					$ (0.04)	$ (0.05)

NOTE 7 - LOSS PER SHARE_ Sche_4

NOTE 7 - LOSS PER SHARE: Schedule of fully diluted shares (Details) - shares	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Details
Basic weighted average shares outstanding	1,135,194	1,135,194
Convertible debt	13,750	11,143
Total	1,148,944	1,146,337